Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
Frequent early multiple sclerosis relapses during treatment with fingolimod: a paradoxical effect?
General health issues in multiple sclerosis: comorbidities, secondary conditions, and health behaviors.
Chromosomal radiosensitivity in patients with multiple sclerosis.
Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain.
Effects of balance-specific exercises on balance, physical activity and quality of life in adults with multiple sclerosis: a pilot investigation.
DSM-III disorders from age 11 to age 15 years.
Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIMS Meeting
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01)
Multiple sclerosis: Efficacy of fingolimod confirmed on all MRI end points.
Antibodies Against Human BLyS and APRIL Attenuate EAE Development in Marmoset Monkeys.
Diagnosis and differential diagnosis of multiple sclerosis.
Analyzing differences between patient and proxy on Patient Reported Outcomes in multiple sclerosis.
Constraint-Induced Movement Therapy for the Lower Extremities in Multiple Sclerosis: Case Series with 4-Year Follow-up.
The effects of clinical interventions on health-related quality of life in multiple sclerosis: a meta-analysis.
Copy number variation in pediatric multiple sclerosis.
Neuroinflammation as the proximate cause of signature pathogenic pattern progression in amyotrophic lateral sclerosis, AIDS, and multiple sclerosis.
[Contrast agents in MRI-diagnosis of multiple sclerosis].
Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models.
Multiple deep white matter lesions mimicking multiple sclerosis as an unusual complication of a left atrial myxoma.
Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in mice.
Leg spasticity and ambulation in multiple sclerosis.
Oral simvastatin treatment in relapsing-remitting multiple sclerosis.
Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis.
Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation.

Pages